Assessing multiple sclerosis activity: Is the in vitro production of tumor necrosis factor-α, interleukins 2, 6, 4, and 10, and immunoglobulin G of value?

Journal of Neurology

Volumn 246, Issue 11, 1999, Pages 1041-1050

  Schluep, Myriam ^a   Van Melle, Guy ^b   Henry, Hugues ^c   Städler, Claudio ^a   Roth Wicky, Béatrice ^a   Magistretti, Pierre J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Cytokines; Immunoglobulin G; Multiple sclerosis

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CONCANAVALIN A; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CLINICAL FEATURE; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DISEASE ACTIVITY; HUMAN; IMMUNITY; LEUKOCYTE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; STIMULATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ADRENAL CORTEX HORMONES; ASTHENIA; AZATHIOPRINE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-BETA; INTERLEUKINS; MULTIPLE SCLEROSIS; OLIGOCLONAL BANDS; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032733990     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050510     Document Type: Article

References (54)

1. 1. Barrett KA, Guthikonda P, Goodman A, Mattson D (1996) The effect of in vitro and in vivo interferon-β 1b on immunoglobulin G synthesis by peripheral blood lymphocytes. Neurology 46 [Suppl] : A 136-A 137
2. 2. Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J (1988) Increased production of Interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand 78 : 318-323
3. 3. Brod SA, Marshall GD Jr, Henninger EM, Sriram S, Kjan M, Wolinsky JS (1996) Interferon-β1b treatment decreases tumor necrosis factor-α and increases interleukin-6 production in multiple sclerosis. Neurology 46 : 1633-1638
4. 4. Chofflon M, Juillard C, Juillard P, Gauthier G, Grau GE (1992) Tumor necrosis factor-α production as a possible predictor of relapse in patients with multiple sclerosis. Eur Cytokine Netw 3 : 523-531
5. 5. Crilly A, McInnes IB, Capell HA, Madhok R (1994) The effect of azathioprine on serum levels of interleukin-6 and soluble interleukin-2 receptor. Scand J Rheumatol 23 : 87-91
6. 6. Daftarian PM, Kumar A, Kryworuchko M, Diazmitoma F (1996) IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. J Immunol 157 : 12-20
7. 7. Dayal AS, Jensen MA, Lledo A, Arnason BGW (1995) Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon-beta-1b. Neurology 45 : 2173-2177
8. 8. DeForge LE, Remick DG (1991) Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole blood. Biochem Biophys Res Commun 174 : 18-24
9. 9. Djaldetti R, Ziv I, Achiron A, Melamed E (1996) Fatigue in multiple sclerosis compared with chronic fatigue syndrome - a quantitative assessment. Neurology 46 : 632-635
10. 10. Eggesbo JB, Hjermann I, Lund PK, Joo GB, Ovstebo R, Kierulf P, Eggesbo JB, Hjermann I, Lund PK, Joo GB, Ovstebo R, Kierulf P (1994) LPS-induced release of IL-1β, IL-6, IL-8, TNF-α and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine 6 : 521-529
11. 11. Espevik T, Nissen-Meyer JN (1986) A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95 : 99-105
12. 12. Friedman A, Weiner HL (1994) Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91 : 6688-6692
13. 13. Hammerling U, Henningsson A-C, Sjödin L (1992) Development and validation of a bioassay for interleukin-2. J Pharm Biomed Anal 10 : 547-555
14. 14. Hansen MB, Nielsen SE, Berg K (1989) Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 119 : 203-210
15. 15. Hardin J, McLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H, Epstein J (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84 : 3063-3070
16. 16. Imamura K, Suzumura A, Hayashi F, Marunouchi T (1993) Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients. Acta Neurol Scand 87 : 281-285
17. 17. Keir G, Luxton RW, Thompson EJ (1990) Isoelectric focusing of cerebrospinal fluid immunoglobulin G: an annotated update. Ann Clin Biochem 27 : 436-443
18. 18. Kennedy MK, Torrance DS, Picha KS, Mohler KM (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149 : 2496-2505
19. 19. Khoury SJ, Hancock WW, Weiner HL (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4 and prostaglandin E expression in the brain. J Exp Med 176 : 1355-1364
20. 20. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, Zinkernagel R, Bluethmann H, Köhler G (1994) Impaired immune and acute phase responses in interleukin-6-deficient mice. Nature 368 : 339-342
21. 21. Kunicka JE, Talle MA, Denhardt H, Brown M, Prince LA, Goldstein G (1993) Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol 149 : 39-49
22. 22. Landegren U (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67 : 379-388
23. 23. Le J, Vilcek J (1989) Biology of disease - interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase response. Lab Invest 61 : 588-602
24. 24. Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu H-C, Lassmann H, Wekerle H (1993) T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur J Immunol 23 : 1363-1372
25. 25. Link J, Söderström M, Olsson T, Höjeberg B, Ljungdahl A, Link H (1994) Increased transforming growth factor-β, interleukin-4, and interferon-γ in multiple sclerosis. Ann Neurol 36 : 379-386
26. 26. Lu C-Z, Jensen MA, Arnason BGW (1993) Interferon-β-and interleukin-4-secreting cells in multiple sclerosis. J Neuroimmunol 46 : 123-128
27. 27. Maimone D, Reder AT, Gregory S (1993) T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis. Cell Immunol 146 : 96-106
28. 28. Matusevicius D, Navikas V, Soderstrom M, Xiao BG, Haglund M, Fredrikson S, Link H (1996) Multiple sclerosis - the proinflammatory cytokines lymphotoxin-alpha and tumour necrosis factor-alpha are upregulated in cerebrospinal fluid mononuclear cells. J Neuroimmunol 66 : 115-123
29. 29. McDonald WI (1986) The mystery of the origin of multiple sclerosis. J Neurol Neurosurg Psychiatry 49 : 434-445
30. 30. Moreau T, Coles A, Wing M, Isaacs J, Hale G, Waldmann H, Compston A (1996) Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis. Brain 119 : 225-237
31. 31. Mosmann TR (1994) Properties and functions of interleukin-10. Adv Immunol 56 : 1-26
32. 32. Navikas V, Matusevicius D, Soderstrom M, Fredrikson S, Kivisakk P, Ljungdahl A, Hojeberg B, Link H (1996) Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 64 : 63-69
33. 33. Noronha A, Toscas A, Jensen MA (1993) Interferon β decreases T cell activation and Interferon γ production in multiple sclerosis. J Neuroimmunol 46 : 145-153
34. 34. Olsson T (1995) Cytokine-producing cells in experimental autoimmune encephalomyelitis and multiple sclerosis. Neurology 45[Suppl 6] : S11-S15
35. 35. Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA (1994) Dysregulation expression of tumor necrosis factor in chronic fatigue syndrome -interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 18 [Suppl 1]: S 147-S 153
36. 36. Perez L, Alvarez-Cermeno JC, Rodriguez C, Roldan E, Brieva JA (1995) B cells capable of spontaneous IgG secretion in cerebrospinal fluid from patients with multiple sclerosis: dependency on local IL-6 production. Clin Exp Immunol 101 : 449-452
37. 37. Poll T van der, Jansen J, Endert E, Sauerwein HP, van Deventer DJH (1994) Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect Immun 62 : 2046-2050
38. 38. Porrini AM, Gambi D, Reder AT (1995) Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J Neuroimmunol 61 : 27-34
39. 39. Rep MHG, Hintzen RQ, Polman CH, Vanlier RAW (1996) Recombinant interferon-beta blocks proliferation but enhances interleukin-10 secretion by activated human T-cells. J Neuroimmunol 67 : 111-118
40. 40. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Poser S (1994) Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 44 : 1523-1526
41. 41. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Lüer W, Helwig A, Poser S (1995) Tumor necrosis factor-α messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity. Ann Neurol 37 : 82-88
42. 42. Rott O, Fleischer B, Cash E (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24 : 1434-1440
43. 43. Rovaris M, Barnes D, Woodrofe N, Duboulay GH, Thorpe JW, Thompson AJ, McDonald WI, Miller DH (1996) Patterns of disease activity in multiple sclerosis patients - a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups. J Neurol 243 : 536-542
44. 44. Rudick RA, Ransohoff RM, Peppler R, VanderBrug Medendorp S, Lehmann P, Alam J (1996) Interferon-beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol 40 : 618-627
45. 45. Salmaggi A, Corsini E, La Mantia L, Dufour A, Eoli M, Milanese C, Nespolo A (1997) Immunological monitoring of azathioprine treatment in multiple sclerosis patients. J Neurol 244 : 167-174
46. 46. Schattner A (1994) Lymphokines in autoimmunity - a critical review. Clin Immunol Immunopath 70 : 177-184
47. 47. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA (1990) Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75 : 40-47
48. 48. Thorpe JW, Kidd D, Moseley IF, Kendall BE, Thompson AJ, MacManus DG, McDonald WI, Miller DH (1996) Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis. Neurology 46 : 373-378
49. 49. Waksman BH (1985) Mechanisms in multiple sclerosis. Nature 318 : 104-105
50. 50. Wang P, Wu P, Siegel MI, Egan RW, Billah MM (1994) IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 153 : 811-816
51. 51. Warren KG, Catz I, Johnson E, Mielke B (1994) Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis. Ann Neurol 35 : 280-289
52. 52. Zaffaroni M, Galli Stampino L, Ghezzi A, Baldini SM, Zibetti A (1995) In vitro cytokine, sCD23 and IgG secretion in multiple sclerosis. J Neuroimmunol 61 : 1-5
53. 53. Zeman AZJ, Keir G, Luxton R, Thompson EJ (1996) Serum oligoclonal Igg is a common and persistent finding in multiple sclerosis, and has a systemic source. Q J Med 89 : 187-193
54. 54. Zeman AZJ, Kidd D, McLean BN, Kelly MA, Francis DA, Miller DH, Kendall BE, Rudge P, Thompson EJ, McDonald WI (1996) A study of oligoclonal band negative multiple sclerosis. J Neurol Neurosurg Psychiatry 60 : 27-30